Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01404962
What this trial is testing

Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

Who this might be right for
Haemophilus Influenzae Type B Infection
Novartis Vaccines 764
Large-scale testing (Phase 3)Study completedNCT05457946
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 60
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Large-scale testing (Phase 3)Study completedNCT00907777
What this trial is testing

Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 52
Post-approval studies (Phase 4)Study completedNCT01896596
What this trial is testing

Hepatitis B Vaccination in Infants

Who this might be right for
Meningococcal DiseasePneumococcal DiseaseHaemophilus Influenzae Serotype b Disease+2 more
Public Health England 300
Large-scale testing (Phase 3)Study completedNCT00332566
What this trial is testing

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

Who this might be right for
Hepatitis BWhole Cell PertussisTetanus+2 more
GlaxoSmithKline 148
Large-scale testing (Phase 3)Study completedNCT00317109
What this trial is testing

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 168
Large-scale testing (Phase 3)Study completedNCT03891758
What this trial is testing

Confirmatory Study of BK1310 in Healthy Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Tanabe Pharma Corporation 267
Post-approval studies (Phase 4)Study completedNCT00753649
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Who this might be right for
Hepatitis BTetanusPoliomyelitis+3 more
GlaxoSmithKline 224
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Large-scale testing (Phase 3)Study completedNCT02428491
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 354
Large-scale testing (Phase 3)Study completedNCT02992925
What this trial is testing

Phase 3 Study of BK1310 in Healthy Infants

Who this might be right for
Immunization; Infection
Tanabe Pharma Corporation 370
Not applicableEnded earlyNCT01292213
What this trial is testing

Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom

Who this might be right for
Infections, Respiratory Tract
GlaxoSmithKline 19
Testing effectiveness (Phase 2)Study completedNCT01616459
What this trial is testing

Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 953
Testing effectiveness (Phase 2)Active Not RecruitingNCT07743008
What this trial is testing

Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine

Who this might be right for
Haemophilus InfluenzaeHaemophilus Influenzae Type a
InventVacc Biologicals Inc. 47
Large-scale testing (Phase 3)Study completedNCT00514709
What this trial is testing

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,843
Large-scale testing (Phase 3)Study completedNCT02094833
What this trial is testing

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 310
Large-scale testing (Phase 3)Study completedNCT01978093
What this trial is testing

Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 600
Large-scale testing (Phase 3)Study completedNCT01251133
What this trial is testing

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Who this might be right for
Infectious Disease by Haemophilus Influenzae Type b
LG Life Sciences 122
Large-scale testing (Phase 3)Study completedNCT00861380
What this trial is testing

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 41,188
Next Page